UK MHRA laments funding difficulties
This article was originally published in Clinica
Executive Summary
The UK Medicines and Healthcare products Regulatory Agency wants the world to know of its financial problems – actual or likely. Its newly issued business plan for the current financial year and its corporate plan for the next five years are packed with references to existing or probable funding challenges.